True North Advisors LLC Grows Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

True North Advisors LLC lifted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 11.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 8,756 shares of the company’s stock after purchasing an additional 930 shares during the quarter. True North Advisors LLC owned about 0.06% of U.S. Physical Therapy worth $777,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. State Street Corp boosted its position in U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after buying an additional 99,244 shares during the last quarter. Southernsun Asset Management LLC boosted its holdings in U.S. Physical Therapy by 10.5% in the third quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock valued at $46,302,000 after purchasing an additional 52,062 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in U.S. Physical Therapy by 2.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock valued at $39,173,000 after purchasing an additional 10,462 shares in the last quarter. Geode Capital Management LLC increased its holdings in U.S. Physical Therapy by 1.3% during the 3rd quarter. Geode Capital Management LLC now owns 343,073 shares of the company’s stock worth $29,040,000 after purchasing an additional 4,477 shares during the last quarter. Finally, Rockefeller Capital Management L.P. raised its position in shares of U.S. Physical Therapy by 18.8% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock valued at $13,578,000 after purchasing an additional 25,393 shares in the last quarter.

Analyst Upgrades and Downgrades

USPH has been the topic of several research reports. JPMorgan Chase & Co. upped their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. Barrington Research reiterated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. JMP Securities began coverage on U.S. Physical Therapy in a report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price for the company. Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. Finally, Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $100.00 to $115.00 in a research note on Monday, December 16th. One analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $114.00.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock opened at $90.47 on Thursday. The stock has a market cap of $1.37 billion, a PE ratio of 96.24, a price-to-earnings-growth ratio of 3.71 and a beta of 1.48. U.S. Physical Therapy, Inc. has a 12 month low of $76.18 and a 12 month high of $113.63. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The business has a fifty day simple moving average of $92.48 and a 200-day simple moving average of $88.86.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 15th were issued a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 1.95%. The ex-dividend date of this dividend was Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio is currently 187.23%.

Insider Transactions at U.S. Physical Therapy

In related news, insider Eric Joseph Williams sold 2,000 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $95.84, for a total transaction of $191,680.00. Following the completion of the sale, the insider now owns 14,814 shares in the company, valued at $1,419,773.76. This represents a 11.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the completion of the transaction, the chief financial officer now directly owns 20,469 shares in the company, valued at approximately $1,970,141.25. This represents a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 7,412 shares of company stock valued at $706,605. 1.70% of the stock is owned by insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.